沛嘉醫療公佈2022年中期業績：TaurusOne®及TaurusElite®屢創月度植入量新高
Aug 22, 2022 09:30 HKT |  |
|
Peijia Medical Announces 2022 Interim Results: TaurusOne(R) and TaurusElite(R) Repeatedly Sets New Monthly Highs in Implantation Volume
Aug 22, 2022 09:29 HKT | |
|
华检医疗控股公布二零二二年中期业绩
Aug 22, 2022 07:32 HKT |  |
|
華檢醫療控股公佈二零二二年中期業績
Aug 22, 2022 07:31 HKT | |
|
IVD Medical Announces 2022 Interim Results
Aug 22, 2022 07:30 HKT | |
|
复锐医疗科技公布2022中期业绩
Aug 20, 2022 08:52 HKT |  |
|
復銳醫療科技公佈2022中期業績
Aug 20, 2022 08:51 HKT | |
|
New Horizon Health Announced 2022 Interim Report: Revenue Up 414% YoY, Gross Margin Climbs to 82%
Aug 19, 2022 19:51 HKT |  |
|
Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY
Aug 19, 2022 17:55 HKT |  |
|
台灣精品於 2022 年新加坡國際醫療展首次亮相 展出10 家醫療科技暨照護領域的創新企業
Aug 19, 2022 14:01 HKT |  |
|
台灣精品於 2022 年新加坡國際醫療展首次亮相 展出10 家醫療科技暨照護領域的創新企業
Aug 19, 2022 14:01 HKT | |
|
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022
Aug 19, 2022 14:00 HKT | |
|
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022
Aug 19, 2022 14:00 HKT | |
|
港股稀缺标的百奥赛图今日开启招股
Aug 19, 2022 11:41 HKT | |
|
港股稀缺標的百奧賽圖今日開啟招股
Aug 19, 2022 11:40 HKT | |
|
Sirnaomics核心产品RNAi治疗药物STP705用于治疗面部原位鳞状细胞皮肤癌的I/II期临床试验完成首例受试者给药
Aug 19, 2022 11:32 HKT | |
|
Sirnaomics核心產品RNAi治療藥物STP705用於治療面部原位鱗狀細胞皮膚癌的I/II期臨床試驗完成首例受試者給藥
Aug 19, 2022 11:31 HKT | |
|
Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ
Aug 19, 2022 11:30 HKT | |
|
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU
Aug 18, 2022 18:00 HKT |  |
|
ADC研發浪潮席捲下，四環醫藥（0460.HK）差異化佈局創新
Aug 16, 2022 16:13 HKT | |
|